In this issue:
- Diabetes-related acute metabolic emergencies during COVID-19
- Telemonitoring, telemedicine and time in range during COVID-19
- Impact of lockdown on glucose sensor use
- COVID-19 in Mexico: impact of admission hyperglycaemia on mortality
- COVID-19 and diabetes: from pathophysiology to clinical management
- Post-COVID-19 syndrome and diabetes
- Diabetes, COVID-19 and mucormycosis
- Cycling reduces all-cause and CV mortality in diabetics
- Capillary ketone levels at time of colonoscopy
- Associations of insulin resistance and type 2 diabetes with gut microbiome
- Telehealth for outpatient diabetes management during COVID-19
Please login below to download this issue (PDF)